Overview
Misha Mohindra is a Nephrologist in Salem, Oregon. Dr. Mohindra is rated as an Experienced provider by MediFind in the treatment of Gitelman Syndrome. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Hypophosphatemia, and Hypophosphatasia (HPP). Dr. Mohindra is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
875 Oak St Se, Suite 5070, Salem, OR 97301
University Professional Services
David Ellison is a Nephrologist in Portland, Oregon. Dr. Ellison is rated as a Distinguished provider by MediFind in the treatment of Gitelman Syndrome. His top areas of expertise are Low Potassium Level, High Potassium Level, Pseudohypoaldosteronism Type 2, and Pseudohypoaldosteronism Type 1. Dr. Ellison is currently accepting new patients.
Christina Mehanni is a Nephrologist in Tualatin, Oregon. Dr. Mehanni is rated as an Advanced provider by MediFind in the treatment of Gitelman Syndrome. Her top areas of expertise are Chronic Kidney Disease, Pseudohypoaldosteronism Type 2, Liddle Syndrome, and Hypophosphatemia. Dr. Mehanni is currently accepting new patients.
Legacy Good Samaritan Hospital And Medical Center
Nashila Abdulrahim is a Nephrologist in Portland, Oregon. Dr. Abdulrahim has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Gitelman Syndrome. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Magnesium Deficiency, Gitelman Syndrome, and Kidney Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- End-Stage Renal Disease (ESRD)Dr. Mohindra isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- Advanced
- Childhood Hypophosphatasia (HPP)Dr. Mohindra isAdvanced. Learn about Childhood Hypophosphatasia (HPP).
- Chronic Kidney DiseaseDr. Mohindra isAdvanced. Learn about Chronic Kidney Disease.
- Hypophosphatasia (HPP)Dr. Mohindra isAdvanced. Learn about Hypophosphatasia (HPP).
- HypophosphatemiaDr. Mohindra isAdvanced. Learn about Hypophosphatemia.
- Juvenile Paget's DiseaseDr. Mohindra isAdvanced. Learn about Juvenile Paget's Disease.
- Experienced
- Acute Kidney FailureDr. Mohindra isExperienced. Learn about Acute Kidney Failure.
- Acute Tubular NecrosisDr. Mohindra isExperienced. Learn about Acute Tubular Necrosis.
- Autosomal Dominant HypocalcemiaDr. Mohindra isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Congenital Nephrotic SyndromeDr. Mohindra isExperienced. Learn about Congenital Nephrotic Syndrome.
- Denys-Drash Syndrome (DDS)Dr. Mohindra isExperienced. Learn about Denys-Drash Syndrome (DDS).
- Diffuse Mesangial SclerosisDr. Mohindra isExperienced. Learn about Diffuse Mesangial Sclerosis.